Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Katsutoshi Shoda MD, PhD

Katsutoshi Shoda MD, PhD

Researcher, Department of Molecular Diagnostics and Experimental Therapeutics, Beckman Research Institute of City of Hope, Duarte, California, USA; Assistant Professor, First Department of Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan

Katsutoshi Shoda, MD, PhD, graduated from Kyoto Prefectural University of Medicine, Kyoto, Japan. He is specialized in gastrointestinal surgery and is currently an assistant professor in the First Department of Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan. Additionally, he serves as a researcher at the Department of Molecular Diagnostics and Experimental Therapeutics at the Beckman Research Institute, City of Hope, Duarte, CA.

Dr. Shoda has dedicated his research career to the study of cancer since the beginning of his medical journey and has made significant contributions to the field. His research mainly focused on the biomarkers relevant to treatment using liquid biopsies in upper gastrointestinal cancer. He has been the lead author or contributor to over 100 scientific articles published in peer-reviewed international journals. His research activities are highly regarded nationally and internationally, including prestigious honors.

His research philosophy is "Bedside-to-Bench-to-Bedside.” Based on his experience treating many gastrointestinal cancer patients, he always considers what is needed in today's clinical settings and pursues new possibilities for clinical applications.


Dr. Shoda has no relevant disclosures.